Clinical & Diagnostic
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value R...
October 10, 2023 | News
Thermo Fisher Scientific Expands St. Louis Manufacturing for Complex Biologic Treatments
Thermo Fisher Scientific, the world leader in serving science, expanded its manufacturing capacity in St. Louis to support biologic therapies for dis...
October 06, 2023 | News
Promega & GSK to Create MSI Companion Diagnostic IVD Kit
Promega Corporation today announced it plans to develop and commercialize a microsatellite instability (MSI) companion diagnostic (CDx) IVD kit with G...
October 05, 2023 | News
FDA Clears Transcenta for Global Phase III Trial of Osemitamab in Gastric Cancer
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...
October 04, 2023 | News
ZEISS and Boehringer Ingelheim Collaborate on Early Eye Disease Detection to Prevent Vision Loss.
The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms and the development of first-in-class tr...
October 03, 2023 | News
Bausch + Lomb Completes Acquisition of XIIDRA®
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced it h...
October 02, 2023 | News
PHC and JCR Pharma Release Second Update for "Meron Diary" Growth Hormone Treatment App
Jointly developed by PHC IVD and JCR Pharma and released for the first time in October 2020, "Meron Diary" is a smartphone application that can wirelessly ...
October 02, 2023 | News
Rimegepant Now Available in Hong Kong as First Asian Market for Migraine Management
"As the first market in Asia, we are pleased to bring to Hong Kong this medication for migraine, as we understand how migraine can adversely...
October 02, 2023 | News
BioCity and AstraZeneca Collaborate on Hepatocellular Carcinoma Treatment in China
BioCity will lead the trial, which has received IND approval by the National Medical Products Administration (NMPA). The study will be conducted at Zhongsh...
September 28, 2023 | News
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design
Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design...
September 27, 2023 | News
Bayer Indonesia launches "Bayer For Her" to improve the reproductive health of Indonesian women English
Coinciding with the commemoration of World Contraception Day 2023, Bayer Indonesia launched the "Bayer for Her" campaign, underscoring the i...
September 27, 2023 | News
Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, announced ...
September 26, 2023 | News
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology
"We're thrilled to strengthen our existing suite of patents," said Peter Choo, Chairman of CytoMed. "Now this novel iPSC-based technology has been gra...
September 26, 2023 | News
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients
Many lung cancer patients are grappling with a multitude of symptoms throughout their treatment process, including but not limited to fatigue, reduced appe...
September 26, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
